Natco Pharma - Bottoming Out
Potentially the stock has bottomed out..the management has guided for big earnings going ahead and actively looking for an acquisition based off those earnings.
Technically the stock has been consolidating in the 625-650 range and now there is a double divergence on the RSI as well. The stock is also as close to a channel bottom as possible
Long at current prices with stploss below 600.
Technically the stock has been consolidating in the 625-650 range and now there is a double divergence on the RSI as well. The stock is also as close to a channel bottom as possible
Long at current prices with stploss below 600.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.